Amanda Rose advises life sciences and technology companies with respect to corporate finance, SEC reporting and governance matters. Amanda has represented issuers and underwriters in a wide variety of public and private financing transactions, including initial public offerings, follow-on and secondary offerings, at-the-market offerings, PIPEs and preferred stock and debt financings. She also advises late-stage private companies with respect to general corporate governance and liquidity preparation and public companies on corporate and securities law compliance and disclosure matters, including corporate governance best practices, Exchange Act reporting obligations and stock exchange requirements. Chambers USA ranks Amanda as a top capital markets lawyer, with clients saying, "Amanda stands out as an exceptional young attorney with great judgment, poise, 24/7 availability and extreme attention to detail."
Amanda’s recent capital market transactions have included:
Prior to joining Fenwick & West, Amanda was an associate at an AMLaw 100 firm.
While in law school, Amanda was associate editor for the Seattle University Law Review.